SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028797
Filing Date
2016-11-10
Accepted
2016-11-10 06:32:12
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20160930.htm 10-Q 2054447
2 EX-10.2 pti-ex102_364.htm EX-10.2 144209
3 EX-10.3 pti-ex103_363.htm EX-10.3 135185
4 EX-31.1 pti-ex311_7.htm EX-31.1 12132
5 EX-31.2 pti-ex312_8.htm EX-31.2 12037
6 EX-32.1 pti-ex321_6.htm EX-32.1 13255
7 GRAPHIC g20161109175102457439.jpg GRAPHIC 4990
8 GRAPHIC g20161109175123365440.jpg GRAPHIC 4825
  Complete submission text file 0001564590-16-028797.txt   5773114

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT pti-20160930.xml EX-101.INS 936433
10 XBRL TAXONOMY EXTENSION SCHEMA pti-20160930.xsd EX-101.SCH 35746
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20160930_cal.xml EX-101.CAL 45032
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20160930_def.xml EX-101.DEF 116907
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20160930_lab.xml EX-101.LAB 288412
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20160930_pre.xml EX-101.PRE 220252
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 161985910
SIC: 2834 Pharmaceutical Preparations